{"component": "definition", "props": {"groups": [{"snippet": "means a contract manufacturing organization.", "snippet_links": [{"key": "contract-manufacturing-organization", "type": "definition", "offset": [8, 43]}], "size": 272, "samples": [{"hash": "kdO5ZNnvdcB", "uri": "/contracts/kdO5ZNnvdcB#cmo", "label": "Collaboration and License Agreement (4D Molecular Therapeutics, Inc.)", "score": 37.2080764771, "published": true}, {"hash": "kqUeZBRI8mi", "uri": "/contracts/kqUeZBRI8mi#cmo", "label": "License Agreement (Zenas BioPharma, Inc.)", "score": 37.2026023865, "published": true}, {"hash": "2hRFsFyr0ao", "uri": "/contracts/2hRFsFyr0ao#cmo", "label": "License Agreement (Atrium Therapeutics, Inc.)", "score": 37.1560592651, "published": true}], "hash": "dd337984e88df5e749fd1e31b1b3ef5b", "id": 1}, {"snippet": "means a Third Party contract manufacturing organization.", "snippet_links": [{"key": "contract-manufacturing-organization", "type": "definition", "offset": [20, 55]}], "size": 112, "samples": [{"hash": "2aHYPFELvBE", "uri": "/contracts/2aHYPFELvBE#cmo", "label": "License Agreement (Merus N.V.)", "score": 36.3456535339, "published": true}, {"hash": "3v2jptt94nS", "uri": "/contracts/3v2jptt94nS#cmo", "label": "License Agreement (Merus N.V.)", "score": 36.1567420959, "published": true}, {"hash": "c92Drklh9IM", "uri": "/contracts/c92Drklh9IM#cmo", "label": "Development and Supply Agreement (Metsera, Inc.)", "score": 36.0253257751, "published": true}], "hash": "bba8fbcd8809fc74a464c4f9ec416e6d", "id": 2}, {"snippet": "means a collateralized mortgage obligation. CMOs are either loss share securities issued by a GSE or structured debt instruments representing interests in specified pools of mortgage loans subdivided into multiple classes, or tranches, of securities, with each tranche having different maturities or risk profiles.", "snippet_links": [{"key": "collateralized-mortgage-obligation", "type": "definition", "offset": [8, 42]}, {"key": "issued-by", "type": "clause", "offset": [82, 91]}, {"key": "debt-instruments", "type": "definition", "offset": [112, 128]}, {"key": "of-mortgage-loans", "type": "clause", "offset": [171, 188]}, {"key": "multiple-classes", "type": "definition", "offset": [205, 221]}, {"key": "of-securities", "type": "clause", "offset": [236, 249]}, {"key": "each-tranche", "type": "definition", "offset": [256, 268]}], "size": 27, "samples": [{"hash": "d3h23wJ3qFU", "uri": "https://www.annualreports.com/HostedData/AnnualReportArchive/c/NYSE_CHMI_2023.pdf", "label": "Mortgage", "score": 22.2671260834, "published": false}, {"hash": "4DfnViTFocH", "uri": "https://stocklight.com/stocks/us/nyse-chmi/cherry-hill-mortgage-investment/annual-reports/nyse-chmi-2025-10K-25716410.pdf", "label": "Mortgage", "score": 22.1233062744, "published": false}, {"hash": "7zjLAUjrbym", "uri": "https://investors.chmireit.com/static-files/359b2e4a-3761-42e3-b60e-82dcea905ce7", "label": "Mortgage", "score": 22.0435791016, "published": false}], "hash": "9be6ce7100e7076d74dd3c968c17b244", "id": 3}, {"snippet": "means a Case Management Order entered by the MDL Court, a Federal Court or a State Court.", "snippet_links": [{"key": "case-management-order", "type": "definition", "offset": [8, 29]}, {"key": "mdl-court", "type": "definition", "offset": [45, 54]}, {"key": "federal-court", "type": "definition", "offset": [58, 71]}, {"key": "state-court", "type": "definition", "offset": [77, 88]}], "size": 17, "samples": [{"hash": "2YmvNhVVg68", "uri": "/contracts/2YmvNhVVg68#cmo", "label": "Settlement Agreement", "score": 34.7771720886, "published": true}, {"hash": "eaPYs22TTxS", "uri": "/contracts/eaPYs22TTxS#cmo", "label": "Settlement Agreement", "score": 26.1704311371, "published": true}, {"hash": "6TJV1MFzd6C", "uri": "/contracts/6TJV1MFzd6C#cmo", "label": "Settlement Agreement", "score": 24.1972446442, "published": true}], "hash": "7c6959555dc74ad5e85ce9e926694b5e", "id": 4}, {"snippet": "means any Third Party contract manufacturing organization.", "snippet_links": [{"key": "contract-manufacturing-organization", "type": "definition", "offset": [22, 57]}], "size": 16, "samples": [{"hash": "6JyGfi1bn6i", "uri": "/contracts/6JyGfi1bn6i#cmo", "label": "Manufacturing Rights Agreement (Sutro Biopharma, Inc.)", "score": 35.2286109924, "published": true}, {"hash": "7Z5Vkrbotbn", "uri": "/contracts/7Z5Vkrbotbn#cmo", "label": "Manufacturing Rights Agreement (Vaxcyte, Inc.)", "score": 35.1546897888, "published": true}, {"hash": "3r4GDzN5ZMy", "uri": "/contracts/3r4GDzN5ZMy#cmo", "label": "License Agreement (Vor Biopharma Inc.)", "score": 34.6112251282, "published": true}], "hash": "52e6bf3cb1ea378f55c7390a5adfc644", "id": 5}, {"snippet": "has the meaning set forth in Section 7.1.", "snippet_links": [{"key": "section-71", "type": "definition", "offset": [29, 40]}], "size": 13, "samples": [{"hash": "cuD4xUZu4Ba", "uri": "/contracts/cuD4xUZu4Ba#cmo", "label": "Non Exclusive Collaboration and License Agreement (Skye Bioscience, Inc.)", "score": 37.1861724854, "published": true}, {"hash": "kD2dgLVVlBK", "uri": "/contracts/kD2dgLVVlBK#cmo", "label": "Exclusive License Agreement (Allarity Therapeutics, Inc.)", "score": 33.3723487854, "published": true}, {"hash": "2rLQVGEgVCt", "uri": "/contracts/2rLQVGEgVCt#cmo", "label": "Exclusive License Agreement (Allarity Therapeutics, Inc.)", "score": 33.3723487854, "published": true}], "hash": "ceec2a0e4f5aa9ad79b9001b9b1d6448", "id": 6}, {"snippet": "has the meaning set forth in Section 2.3(a).", "snippet_links": [], "size": 11, "samples": [{"hash": "8Ri9lhjIKLG", "uri": "/contracts/8Ri9lhjIKLG#cmo", "label": "Non Exclusive License Agreement (Metagenomi, Inc.)", "score": 36.8631057739, "published": true}, {"hash": "9e1alhSr9au", "uri": "/contracts/9e1alhSr9au#cmo", "label": "Non Exclusive License Agreement (Environmental Impact Acquisition Corp)", "score": 32.7973976135, "published": true}, {"hash": "1c10Flnsvdf", "uri": "/contracts/1c10Flnsvdf#cmo", "label": "Non Exclusive License Agreement (Omega Therapeutics, Inc.)", "score": 32.5181388855, "published": true}], "hash": "870e46e98809ca9f7c31f868c34c49dc", "id": 7}, {"snippet": "means a THIRD PARTY manufacturer with whom ADAPTIMMUNE has entered into a written agreement for such THIRD PARTY manufacturer to manufacture certain products solely on behalf of ADAPTIMMUNE.", "snippet_links": [{"key": "third-party-manufacturer", "type": "clause", "offset": [8, 32]}, {"key": "entered-into", "type": "clause", "offset": [59, 71]}, {"key": "agreement-for", "type": "clause", "offset": [82, 95]}, {"key": "to-manufacture", "type": "definition", "offset": [126, 140]}, {"key": "certain-products", "type": "clause", "offset": [141, 157]}, {"key": "on-behalf-of", "type": "clause", "offset": [165, 177]}], "size": 10, "samples": [{"hash": "aIuGuDHMMQS", "uri": "/contracts/aIuGuDHMMQS#cmo", "label": "License Agreement", "score": 30.5424633026, "published": true}, {"hash": "ddOrdeRlGmX", "uri": "/contracts/ddOrdeRlGmX#cmo", "label": "Supply Agreement (Adaptimmune Therapeutics PLC)", "score": 27.4695415497, "published": true}, {"hash": "5iDC20xg5kM", "uri": "/contracts/5iDC20xg5kM#cmo", "label": "Sub License Agreement (Adaptimmune Therapeutics PLC)", "score": 26.3278579712, "published": true}], "hash": "c32f0b619659746f717337a6b7f014ba", "id": 8}, {"snippet": "means a collateralized mortgage obligation. CMOs are structured instruments representing interests in specified mortgage loan collateral. CMO securitizations consist of multiple classes, or tranches, of securities, with each tranche having specified characteristics, based on the rules described in the securitization documents governing the division of the monthly principal and interest distributions, including prepayments, from the underlying mortgage collateral among the various tranches.", "snippet_links": [{"key": "collateralized-mortgage-obligation", "type": "definition", "offset": [8, 42]}, {"key": "mortgage-loan-collateral", "type": "definition", "offset": [112, 136]}, {"key": "consist-of", "type": "clause", "offset": [158, 168]}, {"key": "multiple-classes", "type": "definition", "offset": [169, 185]}, {"key": "of-securities", "type": "clause", "offset": [200, 213]}, {"key": "each-tranche", "type": "definition", "offset": [220, 232]}, {"key": "based-on", "type": "definition", "offset": [267, 275]}, {"key": "the-rules", "type": "clause", "offset": [276, 285]}, {"key": "securitization-documents", "type": "definition", "offset": [303, 327]}, {"key": "division-of-the", "type": "clause", "offset": [342, 357]}, {"key": "interest-distributions", "type": "definition", "offset": [380, 402]}, {"key": "mortgage-collateral", "type": "definition", "offset": [447, 466]}], "size": 10, "samples": [{"hash": "ipfshKx5wdf", "uri": "https://stocklight.com/stocks/us/finance-insurance-and-real-estate/nyse-chmi/cherry-hill-mortgage-investment-corporation/annual-reports/nyse-chmi-2015-10K-15701190.pdf", "label": "Mortgage", "score": 14.9986314774, "published": false}, {"hash": "iLVl3CVu7NH", "uri": "https://annualreport.stocklight.com/NYSE/CHMI/14719542.pdf", "label": "Mortgage", "score": 14.9986314774, "published": false}, {"hash": "bmNejTfb0wU", "uri": "https://investors.chmireit.com/static-files/ca3d187e-4e66-4ace-ac27-e6ad83f98b93", "label": "Amendment", "score": 13.9637231827, "published": false}], "hash": "6dc0b5beb30fcd4f19d27f280f7205c9", "id": 9}, {"snippet": "means an adjustable or fixed-rate debt obligation (bond) that is collateralized by Mortgage Loans or mortgage certificates and issued by private institutions or issued or guaranteed by FNMA, FHLMC or GNMA.", "snippet_links": [{"key": "debt-obligation", "type": "clause", "offset": [34, 49]}, {"key": "mortgage-loans", "type": "definition", "offset": [83, 97]}, {"key": "mortgage-certificates", "type": "definition", "offset": [101, 122]}, {"key": "issued-by", "type": "clause", "offset": [127, 136]}, {"key": "private-institutions", "type": "definition", "offset": [137, 157]}, {"key": "guaranteed-by", "type": "clause", "offset": [171, 184]}], "size": 10, "samples": [{"hash": "l7KZHxxtKTi", "uri": "/contracts/l7KZHxxtKTi#cmo", "label": "Annual Report", "score": 25.6543464661, "published": true}, {"hash": "dqsuJbkjmd3", "uri": "/contracts/dqsuJbkjmd3#cmo", "label": "Management Agreement (Imperial Credit Mortgage Holdings Inc)", "score": 18.0, "published": true}, {"hash": "1ZRqGmCGZys", "uri": "/contracts/1ZRqGmCGZys#cmo", "label": "Management Agreement (Hanover Capital Mortgage Holdings Inc)", "score": 18.0, "published": true}], "hash": "dc0d2f1987bf43ba07b07139ff5f7b40", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMY21vIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means a contract manufacturing organization.", "title": "CMO", "size": 837, "id": "cmo", "examples": ["PRELUDE THERAPEUTICS INCORPORATED J\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, M.D. By: /s/ M\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 By: /s/ J\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Name: M\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Name: J\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Title: Chief People Officer Title: President and <strong>CMO</strong> Date: 03 November 2025 Date: 03 November 2025 1.", "In the event the audit takes place at a <strong>CMO</strong>, Halozyme has the right to be on site during the audit and act as an observer between Company and the <strong>CMO</strong>."], "related": [["local-spatial-development-framework", "local spatial development framework", "local spatial development framework"], ["sales-force", "Sales Force", "Sales Force"], ["clinical-development", "Clinical Development", "Clinical Development"], ["spatial-development-framework", "spatial development framework", "spatial development framework"], ["chiropractor", "Chiropractor", "Chiropractor"]], "related_snippets": [], "updated": "2026-04-02T05:49:26+00:00"}, "json": true, "cursor": ""}}